Supplemental material
OncoImmunology
Volume 7, 2018 - Issue 7
Open access
2,384
Views
8
CrossRef citations to date
0
Altmetric
Original Research
Large-scale database mining reveals hidden trends and future directions for cancer immunotherapy
Jakob Nikolas KatherDepartment of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany;Heidelberg Site, German Cancer Consortium (DKTK), Heidelberg, Germany;Clinical Cooperation Unit Applied Tumor Immunity, D120, German Cancer Research Center (DKFZ), Heidelberg, Germanyhttp://orcid.org/0000-0002-3730-5348 http://orcid.org/0000-0002-3730-5348 http://orcid.org/0000-0002-3730-5348
, Anna Sophie BerghoffDepartment of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany;Clinical Unit for Experimental Oncology Therapy, Thoraxklinik, University of Heidelberg, Heidelberg, Germany
, Dyke FerberDepartment of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany;Clinical Cooperation Unit Applied Tumor Immunity, D120, German Cancer Research Center (DKFZ), Heidelberg, Germany
, Meggy Suarez-CarmonaDepartment of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany;Clinical Cooperation Unit Applied Tumor Immunity, D120, German Cancer Research Center (DKFZ), Heidelberg, Germanyhttp://orcid.org/0000-0002-8892-1546
, Constantino Carlos Reyes-AldasoroDepartment of Electrical and Electronic Engineering, School of Mathematics, Computer Science and Engineering, City, University of London, London, UK
, Nektarios A. ValousDepartment of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany;Clinical Cooperation Unit Applied Tumor Immunity, D120, German Cancer Research Center (DKFZ), Heidelberg, Germanyhttp://orcid.org/0000-0002-4014-2404
, Rodrigo Rojas-MoraledaDepartment of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany;Clinical Cooperation Unit Applied Tumor Immunity, D120, German Cancer Research Center (DKFZ), Heidelberg, Germany
, Dirk JägerDepartment of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany;Heidelberg Site, German Cancer Consortium (DKTK), Heidelberg, Germany;Clinical Cooperation Unit Applied Tumor Immunity, D120, German Cancer Research Center (DKFZ), Heidelberg, Germany
& Niels HalamaDepartment of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany;Heidelberg Site, German Cancer Consortium (DKTK), Heidelberg, Germany;Clinical Cooperation Unit Applied Tumor Immunity, D120, German Cancer Research Center (DKFZ), Heidelberg, GermanyCorrespondence[email protected]
show all
Article: e1444412
|
Received 29 Jan 2018, Accepted 16 Feb 2018, Published online: 29 Mar 2018
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.